Abbott Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
NCT Number: NCT00755469
When angioplasty (PTCA) and stenting of the blood vessels of the heart is the treatment for a Heart Attack, there is damage to the heart muscle that is caused by the sudden opening of the blood vessels. This is called "reperfusion injury". The cell death is due to inflammation and the generation of free radicals.
The primary objective of this study is to determine if post-conditioning(four brief (30 second) PTCA balloon inflations) reduces damage to the heart muscle. This will be measured by heart enzyme tests-CK measurements- and by cardiac MRI.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55407, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The post-conditioning protocol consists of performing 4, 30-second PTCA balloon occlusions followed by 30 seconds of reperfusion for a total of 4 minutes. The first balloon inflation occurs immediately after an angioplasty guidewire is placed through the obstruction in the artery and flow is restored. Following this protocol the vessel will be stented as part of usual practice for treatment of acute MI.
Time frame: 3 months
Time frame: 3 months
Minneapolis Heart Institute Foundation
Other
Modification of Reperfusion by "Post-Conditioning" Reduces Infarct Size in Acute Myocardial Infarction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02709798
Cardiovascular Diseases, Heart Diseases
Beijing, China
View Trial DetailsNCT02286544
Acute Coronary Syndrome, Acute Coronary Syndrome (ACS)
Linköping, Sweden
View Trial DetailsNCT01584453
Cardiovascular Diseases, Heart Diseases
Bethnal Green, London, United Kingdom
View Trial DetailsNCT01414452
Cardiovascular Diseases, Heart Diseases
Edegem, Antwerp, Belgium
View Trial Details